Palisade Bio PALI Stock
Palisade Bio Price Chart
Palisade Bio PALI Financial and Trading Overview
| Palisade Bio stock price | 0.72 USD |
| Previous Close | 1.62 USD |
| Open | 1.63 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1400 |
| Day's Range | 1.59 - 1.67 USD |
| 52 Week Range | 1.27 - 30.5 USD |
| Volume | 114.41K USD |
| Avg. Volume | 1.63M USD |
| Market Cap | 10.78M USD |
| Beta (5Y Monthly) | 0.842993 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.19 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.5 USD |
PALI Valuation Measures
| Enterprise Value | -2221859 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.0522876 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 43.12855 |
| Price/Book (mrq) | 0.53452855 |
| Enterprise Value/Revenue | -8.887 |
| Enterprise Value/EBITDA | 0.159 |
Trading Information
Palisade Bio Stock Price History
| Beta (5Y Monthly) | 0.842993 |
| 52-Week Change | -92.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 30.5 USD |
| 52 Week Low | 1.27 USD |
| 50-Day Moving Average | 1.64 USD |
| 200-Day Moving Average | 3.15 USD |
PALI Share Statistics
| Avg. Volume (3 month) | 1.63M USD |
| Avg. Daily Volume (10-Days) | 161.47K USD |
| Shares Outstanding | 6.7M |
| Float | 6.64M |
| Short Ratio | 0.41 |
| % Held by Insiders | 1.98% |
| % Held by Institutions | 3.51% |
| Shares Short | 261.72K |
| Short % of Float | 3.93% |
| Short % of Shares Outstanding | 3.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5580.80% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -73.86% |
| Return on Equity (ttm) | -133.71% |
Income Statement
| Revenue (ttm) | 250K USD |
| Revenue Per Share (ttm) | 0.13 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -13949000 USD |
| Net Income Avi to Common (ttm) | -12683000 USD |
| Diluted EPS (ttm) | -4.21 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.3M USD |
| Total Cash Per Share (mrq) | 1.99 USD |
| Total Debt (mrq) | 291K USD |
| Total Debt/Equity (mrq) | 2.12 USD |
| Current Ratio (mrq) | 10.881 |
| Book Value Per Share (mrq) | 3.012 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13122000 USD |
| Levered Free Cash Flow (ttm) | -7984500 USD |
Profile of Palisade Bio
| Country | United States |
| State | CA |
| City | Carlsbad |
| Address | 7750 El Camino Real |
| ZIP | 92009 |
| Phone | 858 704 4900 |
| Website | https://www.palisadebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.
Q&A For Palisade Bio Stock
What is a current PALI stock price?
Palisade Bio PALI stock price today per share is 0.72 USD.
How to purchase Palisade Bio stock?
You can buy PALI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Palisade Bio?
The stock symbol or ticker of Palisade Bio is PALI.
Which industry does the Palisade Bio company belong to?
The Palisade Bio industry is Biotechnology.
How many shares does Palisade Bio have in circulation?
The max supply of Palisade Bio shares is 4.7M.
What is Palisade Bio Price to Earnings Ratio (PE Ratio)?
Palisade Bio PE Ratio is now.
What was Palisade Bio earnings per share over the trailing 12 months (TTM)?
Palisade Bio EPS is -10.19 USD over the trailing 12 months.
Which sector does the Palisade Bio company belong to?
The Palisade Bio sector is Healthcare.
Palisade Bio PALI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}